4 IDEAYA/GSK presentations of IDE275 (GSK959) and 4 additional presentations across IDE397/MAT2A, IDE161/PARG, PRMT5, and KAT6/7 programs at AACR 2025 IDE275 (GSK959) has demonstrated a potential best ...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Drug Discovery & Development Virtual Event on February ...
New Phase 2 data on tonlamarsen in patients with uncontrolled hypertension to be presented in late-breaking session on Saturday, March 28 Prolaio to present LINK-HF2 research highlighting the role of ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development process for industry and patients. Our two companies are applying AI in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results